Sofinnova Investments, Inc. Cti Biopharma Corp Call Options Transaction History

Sofinnova Investments, Inc.

1 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q4 2022 Feb 13, 2023	BUY	$4.45 - $6.17 $1.82 Million - $2.53 Million	410,000 New	410,000 $2.46 Million

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.